Related Experiment Video
Updated: Dec 13, 2025

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Down syndrome presenting with different hematological manifestations: A case series of four cases
Darilin Shangpliang1, Biswajit Dey1, Jonali Das1
1Department of Pathology, North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences, Shillong, Meghalaya, India.
Insights
Children with Down syndrome (DS) have a higher risk of hematological disorders, including acute leukemia. This case series emphasizes that while transient abnormal myelopoiesis (TAM) and AML-M7 are common, other acute myeloid leukemia (AML) subtypes can also occur in DS.
Area of Science:
- Hematology
- Pediatric Oncology
- Genetics
Background:
- Children with Down syndrome (DS) exhibit a significantly increased risk for hematological malignancies.
- Acute myeloid leukemia (AML), particularly megakaryoblastic leukemia (AML-M7), and transient abnormal myelopoiesis (TAM) are well-documented hematologic conditions associated with DS.
Observation:
- This case series details four children diagnosed with Down syndrome and various hematological conditions.
- The cases included two instances of AML-M7, one of TAM, and one of AML-M2 subtype.
Findings:
- The study underscores the diverse spectrum of hematological disorders in children with DS.
- While TAM and AML-M7 are strongly linked to DS, this series highlights the occurrence of other AML subtypes, such as AML-M2.
Implications:
- These findings expand the understanding of hematologic risks in pediatric Down syndrome.
- Increased awareness of diverse AML subtypes in DS is crucial for accurate diagnosis and management.
Abstract:
Children with Down syndrome (DS) are found to have an increased risk of developing various hematological disorders. Particularly, they have an increased predisposition to acute leukemia, predominantly the myeloid type known as myeloid leukemia of Down syndrome (ML-DS). The major morphological subtype is acute megakaryoblastic leukemia. Approximately 10% of the neonates with DS show a unique disorder known as transient leukemia or transient abnormal myelopoiesis (TAM). Their clinical and morphological features are indistinguishable from acute myeloid leukemia (AML); however, they regress spontaneously within the first few months of life. Here we present a series of four cases with different hematological conditions in children with DS. Of the four cases, two presented with AML-M7, one with TAM, and one case was diagnosed as AML-M2 subtype. This case series highlights the spectrum of hematological disorders in children with DS. Although the majority of the case studies show that TAM and AML-M7 are strongly associated with DS, this case series brings to focus that other AML subtypes may occur as well.
Related Concept Videos
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Chronic Kidney Disease II: Clinical Manifestations
Karyotyping
Meiosis I
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

